These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 2820426
1. In vitro inhibition of the classical pathway of human complement by polymyxin B. Asghar SS, Boot T, van der Helm HJ. Biochem Pharmacol; 1987 Sep 15; 36(18):2927-30. PubMed ID: 2820426 [Abstract] [Full Text] [Related]
2. In vitro inhibition of the classical pathway of human complement by a natural microbial product, colistin sulphate. Asghar SS, de Koster A, van der Helm HJ. Biochem Pharmacol; 1986 Sep 01; 35(17):2917-21. PubMed ID: 3638137 [Abstract] [Full Text] [Related]
5. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes. Brown EJ, Ramsey J, Hammer CH, Frank MM. J Immunol; 1983 Jul 01; 131(1):403-8. PubMed ID: 6602833 [Abstract] [Full Text] [Related]
6. Inhibition of the classical and alternative pathways of human and guinea pig complement by pyran copolymer. Webster GF, McArthur WP. Int Arch Allergy Appl Immunol; 1981 Jul 01; 66(3):304-9. PubMed ID: 6913544 [Abstract] [Full Text] [Related]
7. C3 nephritic factor stabilization of the classic C3 convertase: a role for C2 in C3 nephritic factor activity. McLean RH, Nilson SH. Proc Soc Exp Biol Med; 1979 Jul 01; 161(3):358-63. PubMed ID: 461464 [No Abstract] [Full Text] [Related]
8. Inhibition of complement by a series of substituted 2-aryl-1,3-indandiones: interaction with the fifth component of complement. Asghar SS, Siddiqui AH, van der Goot H, Timmerman H. Mol Immunol; 1986 May 01; 23(5):459-65. PubMed ID: 3748011 [Abstract] [Full Text] [Related]
9. Anti-complement activity of oleanolic acid: an inhibitor of C3-convertase of the classical complement pathway. Kapil A, Sharma S. J Pharm Pharmacol; 1994 Nov 01; 46(11):922-3. PubMed ID: 7897600 [Abstract] [Full Text] [Related]
10. Interaction of desialated guinea pig erythrocytes with the classical and alternative pathways of guinea pig complement in vivo and in vitro. Brown EJ, Joiner KA, Frank MM. J Clin Invest; 1983 Jun 01; 71(6):1710-9. PubMed ID: 6863540 [Abstract] [Full Text] [Related]
12. [Formation of classical C3 convertase during the alternative pathway of human complement activation]. Kozlov LV, Shibanova ED, Zinchenko AA. Biokhimiia; 1987 Apr 01; 52(4):660-6. PubMed ID: 3647798 [Abstract] [Full Text] [Related]
13. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes. Medof ME, Kinoshita T, Nussenzweig V. J Exp Med; 1984 Nov 01; 160(5):1558-78. PubMed ID: 6238120 [Abstract] [Full Text] [Related]
16. An anticomplementary agent, K-76 monocarboxylic acid: its site and mechanism of inhibition of the complement activation cascade. Hong K, Kinoshita T, Miyazaki W, Izawa T, Inoue K. J Immunol; 1979 Jun 01; 122(6):2418-23. PubMed ID: 448130 [Abstract] [Full Text] [Related]
17. The cobra complement system: I. The alternative pathway of activation. Vogel CW, Müller-Eberhard HJ. Dev Comp Immunol; 1985 Jun 01; 9(2):311-25. PubMed ID: 3894085 [Abstract] [Full Text] [Related]
18. Alternative complement pathway activation by C4b deposited during classical pathway activation. Matsushita M, Okada H. J Immunol; 1986 Apr 15; 136(8):2994-8. PubMed ID: 2937839 [Abstract] [Full Text] [Related]